MedTrace Logo

Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial

NCT02103296 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-08-20

No results posted yet for this study

Summary

The goal of this protocol is to establish a randomized clinical trial comparing the use of cord blood vs. infant blood with the primary outcome of comparing both the absolute hemoglobin concentration and the percent change in hemoglobin concentration from baseline around 24 hours of life.

Conditions

Interventions

PROCEDURE

Drawing admission labs from cord blood

PROCEDURE

Drawing admission labs from infant blood

Sponsors & Collaborators

  • C.R.Darnall Army Medical Center

    collaborator FED

  • Walter Reed National Military Medical Center

    collaborator FED

  • United States Naval Medical Center, Portsmouth

    collaborator FED

  • Madigan Army Medical Center

    collaborator FED

  • Tripler Army Medical Center

    collaborator FED

  • Capt Alicia Prescott

    lead FED

Principal Investigators

  • Thornton S Mu, MD · San Antonio Military Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2021-07-25
Completion
2021-07-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02103296 on ClinicalTrials.gov